In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes
Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. ttps://pubmed.ncbi.nlm.nih.gov/35023547
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American College of Physicians
2022
|